Search Results - "Keiding, Ulrik B."

ReactELISA: Monitoring a Carbon Nucleophilic Metabolite by ELISAa Study of Lipid Metabolism by Holmquist, Emil F, B. Keiding, Ulrik, Kold-Christensen, Rasmus, Salomón, Trine, Jørgensen, Karl Anker, Kristensen, Peter, Poulsen, Thomas B, Johannsen, Mogens

“…We here present a conceptually novel reaction-based ELISA principle (ReactELISA) for quantitation of the carbon nucleophilic lipid metabolite acetoacetate. Key…”
Get full text

Synthesis of ent-BE-43547A 1 reveals a potent hypoxia-selective anticancer agent and uncovers the biosynthetic origin of the APD-CLD natural products by Villadsen, Nikolaj L, Jacobsen, Kristian M, Keiding, Ulrik B, Weibel, Esben T, Christiansen, Bjørn, Vosegaard, Thomas, Bjerring, Morten, Jensen, Frank, Johannsen, Mogens, Tørring, Thomas, Poulsen, Thomas B

“…Tumour hypoxia is speculated to be a key driver of therapeutic resistance and metastatic dissemination. Consequently, the discovery of new potent agents that…”
Get full text

Synthesis of ent-BE-43547A1 reveals a potent hypoxia-selective anticancer agent and uncovers the biosynthetic origin of the APD-CLD natural products by Villadsen, Nikolaj L., Jacobsen, Kristian M., Keiding, Ulrik B., Weibel, Esben T., Christiansen, Bjørn, Vosegaard, Thomas, Bjerring, Morten, Jensen, Frank, Johannsen, Mogens, Tørring, Thomas, Poulsen, Thomas B.

“…Tumour hypoxia is speculated to be a key driver of therapeutic resistance and metastatic dissemination. Consequently, the discovery of new potent agents that…”
Get full text

Synthesis of ent-BE-43547A sub(1) reveals a potent hypoxia-selective anticancer agent and uncovers the biosynthetic origin of the APD-CLD natural products by Villadsen, Nikolaj L, Jacobsen, Kristian M, Keiding, Ulrik B, Weibel, Esben T, Christiansen, Bjoern, Vosegaard, Thomas, Bjerring, Morten, Jensen, Frank, Johannsen, Mogens, Toerring, Thomas, Poulsen, Thomas B

“…Tumour hypoxia is speculated to be a key driver of therapeutic resistance and metastatic dissemination. Consequently, the discovery of new potent agents that…”
Get full text